ArticleImmunoHorizons2023
SRF617 Is a Potent Inhibitor of CD39 with Immunomodulatory and Antitumor Properties.
Michael C Warren et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
14 papers cite it
this papercites it
ArticleImmunoHorizons2023
Michael C Warren et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.